Zürcher Nachrichten - Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th

EUR -
AED 4.105635
AFN 72.666438
ALL 91.642726
AMD 404.911742
ANG 2.001354
AOA 1026.268648
ARS 1695.646015
AUD 1.605359
AWG 2.012292
AZN 1.900066
BAM 1.959279
BBD 2.255806
BDT 137.874819
BGN 1.956281
BHD 0.422747
BIF 3351.120477
BMD 1.11794
BND 1.434334
BOB 13.266319
BRL 5.57662
BSD 1.119989
BTN 107.206444
BWP 15.40836
BYN 3.377898
BYR 21911.625612
BZD 2.2526
CAD 1.594898
CDF 2582.441239
CHF 0.931015
CLF 0.027748
CLP 1092.082217
CNY 7.481423
CNH 7.485705
COP 3575.351253
CRC 510.101204
CUC 1.11794
CUP 26.880731
CVE 110.459162
CZK 24.373666
DJF 199.444145
DKK 7.474469
DOP 68.010155
DZD 150.477412
EGP 58.850949
ERN 16.769101
ETB 182.946414
FJD 2.51738
FKP 0.846615
GBP 0.845107
GEL 2.895409
GGP 0.846615
GHS 13.171152
GIP 0.846615
GMD 82.171701
GNF 9853.40817
GTQ 8.56205
GYD 234.21169
HKD 8.773152
HNL 30.064115
HRK 7.53581
HTG 146.669123
HUF 364.768181
IDR 20023.704298
ILS 3.445251
IMP 0.846615
INR 106.415654
IQD 1697.884491
IRR 1989340.838443
ISK 136.209623
JEP 0.846615
JMD 178.486932
JOD 0.792638
JPY 176.927996
KES 145.007669
KGS 97.763777
KHR 4547.196302
KMF 491.893444
KPW 1006.146031
KRW 1502.388451
KWD 0.348194
KYD 0.933357
KZT 504.565938
LAK 25183.717737
LBP 100298.395917
LKR 370.728288
LRD 190.969096
LSL 18.528701
LTL 3.300986
LVL 0.676231
LYD 7.196779
MAD 10.836047
MDL 20.059619
MGA 5051.970585
MKD 61.673754
MMK 2347.847365
MNT 4020.291281
MOP 9.053314
MRU 45.019537
MUR 53.370286
MVR 17.272326
MWK 1942.148597
MXN 20.393698
MYR 4.566895
MZN 71.447628
NAD 18.528701
NGN 1487.978019
NIO 41.212811
NOK 10.689905
NPR 171.532048
NZD 1.997658
OMR 0.429841
PAB 1.119969
PEN 3.856348
PGK 5.005799
PHP 70.210546
PKR 310.107245
PLN 4.38555
PYG 6371.31329
QAR 4.094096
RON 5.332237
RSD 117.409132
RUB 93.82275
RWF 1651.432384
SAR 4.199732
SBD 9.0308
SCR 15.532959
SDG 672.432423
SEK 11.193828
SGD 1.431321
SHP 0.844685
SLE 27.579706
SLL 23442.639764
SOS 640.136666
SRD 42.109416
STD 23139.10259
STN 24.543141
SVC 9.800227
SYP 14535.457125
SZL 18.52289
THB 37.515279
TJS 10.321027
TMT 3.92397
TND 3.350389
TOP 2.691731
TRY 55.189457
TTD 7.616524
TWD 35.905438
TZS 2957.072212
UAH 50.418226
UGX 4626.131678
USD 1.11794
UYU 45.04959
UZS 13328.42832
VES 978.981913
VND 28965.827531
VUV 133.092985
WST 3.104559
XAF 655.957
XAG 0.018438
XAU 0.000266630752
XCD 3.021289
XCG 2.018548
XDR 0.790442
XOF 655.957
XPF 119.331742
YER 264.059843
ZAR 18.463283
ZMK 10062.808251
ZMW 22.232477
ZWL 359.97625
SSP 6437.396829
MXV 2.30306
  • CMSC

    -0.3300

    19.62

    -1.68%

  • BP

    0.4800

    46.73

    +1.03%

  • RYCEF

    0.0800

    18.55

    +0.43%

  • GSK

    0.4200

    46.92

    +0.9%

  • RBGPF

    0.0500

    66.83

    +0.07%

  • BTI

    0.1200

    55.62

    +0.22%

  • NGG

    0.6400

    77.12

    +0.83%

  • AZN

    -0.8700

    158.33

    -0.55%

  • RELX

    0.4100

    36.54

    +1.12%

  • RIO

    -0.4800

    94.3

    -0.51%

  • VOD

    -0.1700

    15.39

    -1.1%

  • BCC

    -0.1600

    73.41

    -0.22%

  • BCE

    0.0800

    18.86

    +0.42%

  • CMSD

    -0.3700

    19.67

    -1.88%

  • JRI

    0.0200

    10.64

    +0.19%

Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th

Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th

BUDAPEST, HUNGARY / ACCESS Newswire / May 28, 2026 / After the strong success of its first edition, the Semmelweis-Richter Journalism Award returns in 2026. Journalists from eligible European countries are invited to submit entries in two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies. The application deadline is June 9, 2026, 23:59 CET.

Text size:

The international award was first launched in 2025 by Semmelweis University, Hungary's leading medical and health sciences university, with the support of Gedeon Richter, a Hungary-based, innovation-focused multinational pharmaceutical company. The award aims to recognise high-quality health journalism and its role in informing the public and shaping health-related debate across Europe.

The first edition attracted wide international interest, with nearly 70 submissions from more than 20 European countries, including the United Kingdom, Germany, and Russia. Entries were published in leading international outlets such as The Times, The Guardian, La República, and Süddeutsche Zeitung.

Building on this strong debut, the award is again open in 2026 in the same two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies.

The organisers are looking for articles that highlight important health issues, address underreported or stigmatized conditions, encourage open public discussion, and help improve understanding and treatment.

An international jury will evaluate submissions based on journalistic quality, depth of reporting, impact and relevance, originality, and clear communication.

Submission guidelines

  • Each applicant may submit up to two articles, one per category.

  • Eligible articles must have been published between March 1, 2025 and March 31, 2026.

  • Print articles must be submitted as a scanned copy; online articles as a public link; paywalled content as a screenshot.

  • Submissions must be in English or include an English translation (the original version must also be provided).

  • Applications must be submitted online at: https://semmelweisrichteraward.com/

Awards

The winners will be announced in the last week of July 2026.
The total prize fund is €45,000. In each category, first prize is €10,000, second prize €7,500, and third prize €5,000.

All six winners will be invited to the award ceremony in October 2026 at Semmelweis University in Budapest, Hungary, with travel and accommodation fully covered.

Contact Information

[email protected]

SOURCE: Gedeon Richter Plc.



View the original press release on ACCESS Newswire

D.Smith--NZN